1-20 of 22
Ken Williams
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Validation of Prediction of Diabetes by the Archimedes Model and Comparison With Other Predicting Models

Michael Stern, MD, Ken Williams, MS, David Eddy, MD, PHD, Richard Kahn, PHD
Journal: Diabetes Care
Diabetes Care 2008;31(8):1670–1671
https://doi.org/10.2337/dc08-0521
Published: 01 August 2008
View article titled, Validation of Prediction of Diabetes by the Archimedes Model and Comparison With Other Predicting Models
Open the PDF for Validation of Prediction of Diabetes by the Archimedes Model and Comparison With Other Predicting Models in another window
Journal Articles

What Is the Best Predictor of Future Type 2 Diabetes?

Muhammad A. Abdul-Ghani, MD, PHD, Ken Williams, MS, Ralph A. DeFronzo, MD, Michael Stern, MD
Journal: Diabetes Care
Diabetes Care 2007;30(6):1544–1548
https://doi.org/10.2337/dc06-1331
Published: 01 June 2007
View article titled, What Is the Best Predictor of Future Type 2 Diabetes?
Open the PDF for What Is the Best Predictor of Future Type 2 Diabetes? in another window
Journal Articles

The National Cholesterol Education Program–Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes

Carlos Lorenzo, MD, Ken Williams, MS, Kelly J. Hunt, PHD, Steven M. Haffner, MD
Journal: Diabetes Care
Diabetes Care 2007;30(1):8–13
https://doi.org/10.2337/dc06-1414
Published: 01 January 2007
View article titled, The National Cholesterol Education Program–Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes
Open the PDF for The National Cholesterol Education Program–Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes in another window
Journal Articles

Polymorphism of the 3′-Untranslated Region of the Leptin Receptor Gene, but Not the Adiponectin SNP45 Polymorphism, Predicts Type 2 Diabetes: A population-based study

Monica Nannipieri, MD, Rosalinda Posadas, PHD, Alessandra Bonotti, BM, Ken Williams, Clicerio Gonzalez-Villalpando, MD, Michael P. Stern, MD, Ele Ferrannini, MD
Journal: Diabetes Care
Diabetes Care 2006;29(11):2509–2511
https://doi.org/10.2337/dc06-0355
Published: 01 November 2006
View article titled, Polymorphism of the 3′-Untranslated Region of the Leptin Receptor Gene, but Not the Adiponectin <em>SNP45</em> Polymorphism, Predicts Type 2 Diabetes: <subtitle>A population-based study</subtitle>
Open the PDF for Polymorphism of the 3′-Untranslated Region of the Leptin Receptor Gene, but Not the Adiponectin <em>SNP45</em> Polymorphism, Predicts Type 2 Diabetes: <subtitle>A population-based study</subtitle> in another window
Journal Articles

Risk of Progression to Type 2 Diabetes Based on Relationship Between Postload Plasma Glucose and Fasting Plasma Glucose

Muhammad A. Abdul-Ghani, MD, PHD, Ken Williams, MS, Ralph DeFronzo, MD, Michael Stern, MD
Journal: Diabetes Care
Diabetes Care 2006;29(7):1613–1618
https://doi.org/10.2337/dc05-1711
Published: 01 July 2006
View article titled, Risk of Progression to Type 2 Diabetes Based on Relationship Between Postload Plasma Glucose and Fasting Plasma Glucose
Open the PDF for Risk of Progression to Type 2 Diabetes Based on Relationship Between Postload Plasma Glucose and Fasting Plasma Glucose in another window
Journal Articles

Geographic Variations of the International Diabetes Federation and the National Cholesterol Education Program–Adult Treatment Panel III Definitions of the Metabolic Syndrome in Nondiabetic Subjects

Carlos Lorenzo, MD, Manuel Serrano-Ríos, MD, María T. Martínez-Larrad, PHD, José L. González-Sánchez, PHD, Segundo Seclén, MD, Arturo Villena, MD, Clicerio Gonzalez-Villalpando, MD, Ken Williams, MS, Steven M. Haffner, MD
Journal: Diabetes Care
Diabetes Care 2006;29(3):685–691
https://doi.org/10.2337/diacare.29.03.06.dc05-1796
Published: 01 March 2006
View article titled, Geographic Variations of the International Diabetes Federation and the National Cholesterol Education Program–Adult Treatment Panel III Definitions of the Metabolic Syndrome in Nondiabetic Subjects
Open the PDF for Geographic Variations of the International Diabetes Federation and the National Cholesterol Education Program–Adult Treatment Panel III Definitions of the Metabolic Syndrome in Nondiabetic Subjects in another window
Journal Articles

Trend in the Prevalence of the Metabolic Syndrome and Its Impact on Cardiovascular Disease Incidence: The San Antonio Heart Study

Carlos Lorenzo, MD, Ken Williams, MS, Kelly J. Hunt, PHD, Steven M. Haffner, MD
Journal: Diabetes Care
Diabetes Care 2006;29(3):625–630
https://doi.org/10.2337/diacare.29.03.06.dc05-1755
Published: 01 March 2006
View article titled, Trend in the Prevalence of the Metabolic Syndrome and Its Impact on Cardiovascular Disease Incidence: <subtitle>The San Antonio Heart Study</subtitle>
Open the PDF for Trend in the Prevalence of the Metabolic Syndrome and Its Impact on Cardiovascular Disease Incidence: <subtitle>The San Antonio Heart Study</subtitle> in another window
Journal Articles

The Prevalence of the Metabolic Syndrome Did Not Increase in Mexico City Between 1990–1992 and 1997–1999 Despite More Central Obesity

Carlos Lorenzo, MD, Ken Williams, MS, Clicerio Gonzalez-Villalpando, MD, Steven M. Haffner, MD
Journal: Diabetes Care
Diabetes Care 2005;28(10):2480–2485
https://doi.org/10.2337/diacare.28.10.2480
Published: 01 October 2005
View article titled, The Prevalence of the Metabolic Syndrome Did Not Increase in Mexico City Between 1990–1992 and 1997–1999 Despite More Central Obesity
Open the PDF for The Prevalence of the Metabolic Syndrome Did Not Increase in Mexico City Between 1990–1992 and 1997–1999 Despite More Central Obesity in another window
Journal Articles

Liver Enzymes, the Metabolic Syndrome, and Incident Diabetes : The Mexico City Diabetes Study

Monica Nannipieri, MD, Clicerio Gonzales, MD, Simona Baldi, PHD, Rosalinda Posadas, PHD, Ken Williams, MSC, Steven M. Haffner, MD, Michael P. Stern, MD, Ele Ferrannini, MD
Journal: Diabetes Care
Diabetes Care 2005;28(7):1757–1762
https://doi.org/10.2337/diacare.28.7.1757
Published: 01 July 2005
View article titled, Liver Enzymes, the Metabolic Syndrome, and Incident Diabetes : <subtitle>The Mexico City Diabetes Study</subtitle>
Open the PDF for Liver Enzymes, the Metabolic Syndrome, and Incident Diabetes : <subtitle>The Mexico City Diabetes Study</subtitle> in another window
Journal Articles

Does the Metabolic Syndrome Improve Identification of Individuals at Risk of Type 2 Diabetes and/or Cardiovascular Disease?

Michael P. Stern, MD, Ken Williams, MS, Clicerio González-Villalpando, MD, Kelly J. Hunt, PHD, Steven M. Haffner, MD
Journal: Diabetes Care
Diabetes Care 2004;27(11):2676–2681
https://doi.org/10.2337/diacare.27.11.2676
Published: 01 November 2004
View article titled, Does the Metabolic Syndrome Improve Identification of Individuals at Risk of Type 2 Diabetes and/or Cardiovascular Disease?
Open the PDF for Does the Metabolic Syndrome Improve Identification of Individuals at Risk of Type 2 Diabetes and/or Cardiovascular Disease? in another window
Includes: Supplementary data
Journal Articles

Using Metabolic Syndrome Traits for Efficient Detection of Impaired Glucose Tolerance

James B. Meigs, MD MPH, Ken Williams, MS, Lisa M. Sullivan, PHD, Kelly J. Hunt, PHD, Steven M. Haffner, MD, Michael P. Stern, MD, Clicerio González Villalpando, MD, Jessica S. Perhanidis, MPH, David M. Nathan, MD, Ralph B. D’Agostino, Jr, PHD, Ralph B. D’Agostino, Sr, PHD, Peter W.F. Wilson, MD
Journal: Diabetes Care
Diabetes Care 2004;27(6):1417–1426
https://doi.org/10.2337/diacare.27.6.1417
Published: 01 June 2004
View article titled, Using Metabolic Syndrome Traits for Efficient Detection of Impaired Glucose Tolerance
Open the PDF for Using Metabolic Syndrome Traits for Efficient Detection of Impaired Glucose Tolerance in another window
Journal Articles

The Metabolic Syndrome as Predictor of Type 2 Diabetes: The San Antonio Heart Study

Carlos Lorenzo, MD, Mayor Okoloise, MS, Ken Williams, MS, Michael P. Stern, MD, Steven M. Haffner, MD
Journal: Diabetes Care
Diabetes Care 2003;26(11):3153–3159
https://doi.org/10.2337/diacare.26.11.3153
Published: 01 November 2003
View article titled, The Metabolic Syndrome as Predictor of Type 2 Diabetes: <subtitle>The San Antonio Heart Study</subtitle>
Open the PDF for The Metabolic Syndrome as Predictor of Type 2 Diabetes: <subtitle>The San Antonio Heart Study</subtitle> in another window
Journal Articles

A Population Perspective on Diabetes Prevention: Whom should we target for preventing weight gain?

James P. Burke, PHD, Ken Williams, MS, K.M. Venkat Narayan, MD, Cynthia Leibson, PHD, Steven M. Haffner, MD, Michael P. Stern, MD
Journal: Diabetes Care
Diabetes Care 2003;26(7):1999–2004
https://doi.org/10.2337/diacare.26.7.1999
Published: 01 July 2003
View article titled, A Population Perspective on Diabetes Prevention: <subtitle>Whom should we target for preventing weight gain?</subtitle>
Open the PDF for A Population Perspective on Diabetes Prevention: <subtitle>Whom should we target for preventing weight gain?</subtitle> in another window
Journal Articles

Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Snijder et al.

Naveed Sattar, MD, PHD, Ken Williams, MS, Thang S. Han, MD, PHD, Clicerio Gonzalez-Villalpando, MD, Michael E.J. Lean, MD, FRCP, Steven M. Haffner, MD, MPH
Journal: Diabetes Care
Diabetes Care 2003;26(5):1657–1658
https://doi.org/10.2337/diacare.26.5.1657
Published: 01 May 2003
View article titled, Prospective Relation of C-Reactive Protein With Type 2 Diabetes: <subtitle>Response to Snijder et al. </subtitle>
Open the PDF for Prospective Relation of C-Reactive Protein With Type 2 Diabetes: <subtitle>Response to Snijder et al. </subtitle> in another window
Journal Articles

Do We Need the Oral Glucose Tolerance Test to Identify Future Cases of Type 2 Diabetes?

Michael P. Stern, MD, Ken Williams, MS, Steven M. Haffner, MD, MPH
Journal: Diabetes Care
Diabetes Care 2003;26(3):940–941
https://doi.org/10.2337/diacare.26.3.940
Published: 01 March 2003
View article titled, Do We Need the Oral Glucose Tolerance Test to Identify Future Cases of Type 2 Diabetes?
Open the PDF for Do We Need the Oral Glucose Tolerance Test to Identify Future Cases of Type 2 Diabetes? in another window
Journal Articles

Prospective Study of C-Reactive Protein in Relation to the Development of Diabetes and Metabolic Syndrome in the Mexico City Diabetes Study

Thang S. Han, MD, PHD, Naveed Sattar, MD, PHD, Ken Williams, MS, Clicerio Gonzalez-Villalpando, MD, Michael E.J. Lean, MD, FRCP, Steven M. Haffner, MD, MPH
Journal: Diabetes Care
Diabetes Care 2002;25(11):2016–2021
https://doi.org/10.2337/diacare.25.11.2016
Published: 01 November 2002
View article titled, Prospective Study of C-Reactive Protein in Relation to the Development of Diabetes and Metabolic Syndrome in the Mexico City Diabetes Study
Open the PDF for Prospective Study of C-Reactive Protein in Relation to the Development of Diabetes and Metabolic Syndrome in the Mexico City Diabetes Study in another window
Journal Articles

Predicting Future Cardiovascular Disease: Do we need the oral glucose tolerance test?

Michael P. Stern, MD, Pedram Fatehi, MPH, Ken Williams, MS, Steven M. Haffner, MD
Journal: Diabetes Care
Diabetes Care 2002;25(10):1851–1856
https://doi.org/10.2337/diacare.25.10.1851
Published: 01 October 2002
View article titled, Predicting Future Cardiovascular Disease: <subtitle>Do we need the oral glucose tolerance test?</subtitle>
Open the PDF for Predicting Future Cardiovascular Disease: <subtitle>Do we need the oral glucose tolerance test?</subtitle> in another window
Journal Articles

All-Cause and Cardiovascular Mortality Among Diabetic Participants in the San Antonio Heart Study: Evidence against the “Hispanic Paradox”

Kelly J. Hunt, PHD, Ken Williams, MS, Roy G. Resendez, MA, Helen P. Hazuda, PHD, Steve M. Haffner, MD, Michael P. Stern, MD
Journal: Diabetes Care
Diabetes Care 2002;25(9):1557–1563
https://doi.org/10.2337/diacare.25.9.1557
Published: 01 September 2002
View article titled, All-Cause and Cardiovascular Mortality Among Diabetic Participants in the San Antonio Heart Study: <subtitle>Evidence against the “Hispanic Paradox”</subtitle>
Open the PDF for All-Cause and Cardiovascular Mortality Among Diabetic Participants in the San Antonio Heart Study: <subtitle>Evidence against the “Hispanic Paradox”</subtitle> in another window
Journal Articles

Homeostasis Model Assessment of Insulin Resistance in Relation to the Incidence of Cardiovascular Disease: The San Antonio Heart Study

Anthony J.G. Hanley, PhD, Ken Williams, MSc, Michael P. Stern, MD, Steven M. Haffner, MD
Journal: Diabetes Care
Diabetes Care 2002;25(7):1177–1184
https://doi.org/10.2337/diacare.25.7.1177
Published: 01 July 2002
View article titled, Homeostasis Model Assessment of Insulin Resistance in Relation to the Incidence of Cardiovascular Disease: <subtitle>The San Antonio Heart Study</subtitle>
Open the PDF for Homeostasis Model Assessment of Insulin Resistance in Relation to the Incidence of Cardiovascular Disease: <subtitle>The San Antonio Heart Study</subtitle> in another window
Journal Articles

Insulin Sensitivity Does Not Account for Differences in Type 2 Diabetes Incidence Between San Antonio, Texas and Mexico City, Mexico

James P. Burke, PHD, Ken Williams, MS, Steven M. Haffner, MD, Clicerio Gonzalez Villalpando, MD, FACP, Michael P. Stern, MD
Journal: Diabetes Care
Diabetes Care 2002;25(5):938–939
https://doi.org/10.2337/diacare.25.5.938
Published: 01 May 2002
View article titled, Insulin Sensitivity Does Not Account for Differences in Type 2 Diabetes Incidence Between San Antonio, Texas and Mexico City, Mexico
Open the PDF for Insulin Sensitivity Does Not Account for Differences in Type 2 Diabetes Incidence Between San Antonio, Texas and Mexico City, Mexico in another window